Author

WS Liang

Institutions: Translational Genomics Research Institute, Mayo Clinic, University of California, San Francisco, University of Alabama at Birmingham, Natera (United States), University of Pennsylvania

Observed institutions: Translational Genomics Research Institute, Mayo Clinic, University of California, San Francisco, University of Alabama at Birmingham, Natera (United States), University of Pennsylvania

OpenAlex ID: A5084723808

Abstract PD2-01: Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant therapy and outcome in the I-SPY 2 TRIAL

2019 · MJM Magbanua, L Brown-Swigart, et al. · Cancer Research · 9

Works count: 1

Citation count: 9

H-index: 1

I10-index: